Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07255248 · ClinicalTrials.gov registry record · Phase 4
Hoffa's Fat Pad Impingement (HFPI)
A Phase 4 study of Hoffa's Fat Pad Impingement, sponsored by Boston Children's Hospital.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 62
- Enrollment target
- 1
- Study location
NCT07255248 is a Phase 4 study of Hoffa's Fat Pad Impingement that is actively recruiting participants, run by Boston Children's Hospital. The registered enrollment target is 62 participants. The trial reports 1 study location across 1 state.
The verdict
NCT07255248, a Phase 4 study of Hoffa's Fat Pad Impingement, is actively recruiting participants, sponsored by Boston Children's Hospital.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 62 participants
- Enrollment target
- 1
- Study location
Study Summary
The aim of the study is to investigate treatment outcomes for refractory anterior knee pain due to Hoffa's Fat Pad Impingement (HFPI) in young female athletes. Specifically, the study team will study pediatric female athletes with HFPI, and treatment outcomes of US-guided Hoffa's Fat Pad (HFP) corticosteroid injection compared to standard care (physical therapy, bracing, no injection) and saline injection. There will be two arms in this study, 1, a corticosteroid injection and physical therapy and 2, physical therapy and a saline injection. The intent of this study is to measure treatment outcomes, and the research team is not looking at the safety and effectiveness of the lidocaine-methylprednisolone mixture.
Conditions Studied
Interventions
- DRUG methylprednisolone acetate and lidocaine
- DRUG Saline injection (Octreotide LAR placebo)
Study Locations (1)
Massachusetts
- Boston Children's Hospital - Norwood
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 62 participants |
| Start Date | 2026-03-01 |
| Est. Completion | 2028-01-02 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07255248
The ClinicalTrials.gov registry entry for NCT07255248 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 62 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Children's Hospital, which has 462 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Hoffa's Fat Pad Impingement appearing as the primary indexed condition, and to 2 interventions - of which methylprednisolone acetate and lidocaine is the first listed.
NCT07255248 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT07255248 about?
NCT07255248 is a clinical study titled "Hoffa's Fat Pad Impingement (HFPI)". The aim of the study is to investigate treatment outcomes for refractory anterior knee pain due to Hoffa's Fat Pad Impingement (HFPI) in young female athletes. Specifically, the study team will study pediatric female athletes with HFPI, and treatment outcomes of US-guided Hoffa's Fat Pad (HFP) corti...
What is the current status of trial NCT07255248?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 62 participants. The study started on 2026-03-01. Estimated completion is 2028-01-02.
What conditions does trial NCT07255248 study?
This clinical trial studies the following conditions: Hoffa's Fat Pad Impingement.
What interventions are being tested in trial NCT07255248?
The interventions under investigation include: methylprednisolone acetate and lidocaine (DRUG), Saline injection (Octreotide LAR placebo) (DRUG).
Who is sponsoring clinical trial NCT07255248?
This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07255248 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.